Merus N.V. (MRUS)
NASDAQ: MRUS · IEX Real-Time Price · USD
+0.02 (0.04%)
Jul 11, 2024, 4:00 PM EDT - Market closed

Merus Revenue

Merus had revenue of $38.34M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $7.89M. In the year 2023, Merus had annual revenue of $43.95M with 5.68% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.70B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202343.95M2.36M5.68%
Dec 31, 202241.59M-7.52M-15.32%
Dec 31, 202149.11M19.16M64.00%
Dec 31, 202029.94M-1.19M-3.82%
Dec 31, 201931.13M-7.25M-18.88%
Dec 31, 201838.38M14.27M59.20%
Dec 31, 201724.11M21.35M773.11%
Dec 31, 20162.76M665.50K31.76%
Dec 31, 20152.10M662.20K46.20%
Dec 31, 20141.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.56B
Alkermes 1.73B
Integer Holdings 1.63B
Neogen 929.24M
Waystar Holding 824.72M
Guardant Health 603.73M
Ultragenyx Pharmaceutical 442.59M
Axsome Therapeutics 251.02M
Revenue Rankings